Covid Vaccine Efficacy
- All
- News
- Videos
-
Trump-Backed Panel Questions Safety, Efficacy Of Covid-19 Vaccine Shots
A Trump-backed health panel questioned Friday the efficacy and safety of Covid-19 vaccines -- and declined explicitly to recommend them -- in an argument some experts said center on "myths" and "anecdotes."
-
No Clear Link Between Covid Vaccine And Sudden Cardiac Arrest Deaths: Delhi AIIMS
A day after the Indian Council of Medical Research debunked claims of the Corona vaccine being responsible for the rising death cases among the youth, a panel of expert doctors from the All India Institute of Medical Sciences addressed the issue.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Sudden Covid Outbreaks Show "Lack Of Efficacy" Of Chinese Vaccines: Report
China's sudden COVID-19 outbreaks "demonstrate a lack of effectiveness of its vaccines", prompting global concerns, particularly in nations where Beijing's vaccines have been accepted, Tibet Press reported.
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
-
Covid Vaccination Improves Efficacy Of Cancer Treatment, Says Study
Researchers were concerned that Covid vaccine would reduce the effectiveness of drugs used to treat nasopharyngeal cancer, a type of throat cancer, but a new study shows the opposite.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
US Health Authority Says Moderna Covid Vaccine Effective In Under-Fives
US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its Covid-19 vaccine among very young children were accurate.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
-
Trump-Backed Panel Questions Safety, Efficacy Of Covid-19 Vaccine Shots
A Trump-backed health panel questioned Friday the efficacy and safety of Covid-19 vaccines -- and declined explicitly to recommend them -- in an argument some experts said center on "myths" and "anecdotes."
-
No Clear Link Between Covid Vaccine And Sudden Cardiac Arrest Deaths: Delhi AIIMS
A day after the Indian Council of Medical Research debunked claims of the Corona vaccine being responsible for the rising death cases among the youth, a panel of expert doctors from the All India Institute of Medical Sciences addressed the issue.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Sudden Covid Outbreaks Show "Lack Of Efficacy" Of Chinese Vaccines: Report
China's sudden COVID-19 outbreaks "demonstrate a lack of effectiveness of its vaccines", prompting global concerns, particularly in nations where Beijing's vaccines have been accepted, Tibet Press reported.
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
-
Covid Vaccination Improves Efficacy Of Cancer Treatment, Says Study
Researchers were concerned that Covid vaccine would reduce the effectiveness of drugs used to treat nasopharyngeal cancer, a type of throat cancer, but a new study shows the opposite.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
US Health Authority Says Moderna Covid Vaccine Effective In Under-Fives
US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its Covid-19 vaccine among very young children were accurate.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
